The European Commission has promised 30 million Euro ($41 million) to fund 41 institutions across Europe to study the epigenome as a part of a project called BLUEPRINT. The EC's project is one arm of the International Epigenome Consortium (IHEC), which was started last year. The IHEC will coordinate the efforts of member agencies from the EU, United States, Japan, and other countries to generate a reference epigenome that can be used in much the same way that the human genome is used by researchers today.

"BLUEPRINT is the first big epigenome project to be specifically created in alignment with the IHEC mission," Peter Jones from the University of Southern California told Nature. The project will focus on generating the epigenomes of 60 different blood cell types from samples in United Kingdom's national blood bank. In addition, they will compare some of the markers...

"Blood epigenomes are particularly exciting because we know an awful lot about the biology of how blood stem cells differentiate, but little about the sequence of epigenomic events involved in the processes that are going to be relevant for disease," Jones, who is part of IHEC's scientific steering committee, told Nature.

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?